Clinigen Group PLC (LON:CLIN) insider Shaun Edward Chilton sold 100,000 shares of the business’s stock in a transaction dated Friday, October 13th. The shares were sold at an average price of GBX 1,150 ($15.18), for a total value of £1,150,000 ($1,517,550.80).
Shares of Clinigen Group PLC (LON CLIN) opened at 1126.00 on Friday. Clinigen Group PLC has a 12 month low of GBX 695.00 and a 12 month high of GBX 1,175.00. The firm’s 50-day moving average price is GBX 1,106.00 and its 200-day moving average price is GBX 970.79. The stock’s market capitalization is GBX 1.30 billion.
Clinigen Group PLC (LON:CLIN) last announced its quarterly earnings data on Thursday, September 28th. The company reported GBX 41.80 ($0.55) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of GBX 41.20 ($0.54) by GBX 0.60 ($0.01). Clinigen Group PLC had a net margin of 0.70% and a return on equity of 0.98%. The company had revenue of £302.30 million during the quarter.
The firm also recently declared a dividend, which will be paid on Friday, December 1st. Stockholders of record on Thursday, November 9th will be issued a GBX 3.40 ($0.04) dividend. The ex-dividend date of this dividend is Thursday, November 9th. This is a positive change from Clinigen Group PLC’s previous dividend of $1.60. This represents a dividend yield of 0.32%.
TRADEMARK VIOLATION NOTICE: This report was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another site, it was stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this report can be accessed at https://www.dispatchtribunal.com/2017/10/28/insider-selling-clinigen-group-plc-clin-insider-sells-1150000-in-stock.html.
CLIN has been the subject of several recent research reports. Peel Hunt upgraded Clinigen Group PLC to a “buy” rating and boosted their target price for the stock from GBX 1,200 ($15.84) to GBX 1,350 ($17.81) in a research report on Tuesday, October 10th. Numis Securities Ltd downgraded Clinigen Group PLC to an “add” rating and set a GBX 1,100 ($14.52) target price on the stock. in a research report on Tuesday, July 18th.
Clinigen Group PLC Company Profile
Receive News & Ratings for Clinigen Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.